Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RITA-1: FE 999049 in Controlled Ovarian Stimulation
NCT03740737Phase 3Completed
- Sponsor
- Ferring Pharmaceuticals
- Start
- Oct 2018
- Primary completion
- Nov 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in infertility comparing FE 999049 with Placebo (2 arms). Primary endpoint: Cumulative Ongoing Pregnancy Rate After the Fresh Cycle and Cryopreserved Cycles Initiated Within 12 Months From the Start of COS. Started Oct 2018; status: completed.
02
Drugs
follitropin delta
03
Conditions
infertility
Beyond the preview
Go deeper on NCT03740737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03740737.